Provided by Tiger Trade Technology Pte. Ltd.

Privia Health Group, Inc.

21.20
+0.18000.86%
Pre-market: 21.400.1950+0.92%04:01 EDT
Volume:983.97K
Turnover:20.69M
Market Cap:2.71B
PE:96.68
High:21.23
Open:21.04
Low:20.82
Close:21.02
52wk High:28.82
52wk Low:19.53
Shares:127.73M
Float Shares:115.42M
Volume Ratio:1.13
T/O Rate:0.85%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.2193
EPS(LYR):0.1800
ROE:4.31%
ROA:2.03%
PB:3.46
PE(LYR):117.78

Loading ...

Top Privia Health Executive Makes Notable Stock Move That Investors Are Watching

TIPRANKS
·
Apr 07

Analysts Offer Insights on Healthcare Companies: Privia Health Group (PRVA), Nuvalent (NUVL) and Tonix Pharma (TNXP)

TIPRANKS
·
Apr 06

Privia Health publishes 2025 annual report, revenue rises 22.3% to $2.12 billion

Reuters
·
Apr 02

Privia Health Group announces annual shareholder meeting via webcast

Reuters
·
Apr 02

Privia Health Is Maintained at Equal-Weight by Barclays

Dow Jones
·
Mar 25

Privia Health Group Inc. : Barclays Raises Target Price to $25 From $23

THOMSON REUTERS
·
Mar 25

Is It Time To Reassess Privia Health Group (PRVA) After Prolonged Share Price Weakness?

Simply Wall St.
·
Mar 25

Piper Sandler Reaffirms Their Buy Rating on Privia Health Group (PRVA)

TIPRANKS
·
Mar 19

Top Brass Cash Out: Major Insider Moves Rock Privia Health Group

TIPRANKS
·
Mar 19

Privia Health price target raised to $35 from $33 at JPMorgan

TIPRANKS
·
Mar 08

BTIG Reaffirms Their Buy Rating on Privia Health Group (PRVA)

TIPRANKS
·
Mar 05

Privia Health Earnings Call Highlights Growth And Cash

TIPRANKS
·
Mar 05

Privia Health Is Maintained at Buy by Citigroup

Dow Jones
·
Mar 04

Privia Health partners with Amalgam Rx and Exact Sciences on colorectal cancer screening program

Reuters
·
Mar 03

Marking National Colorectal Cancer Awareness Month, Privia Health Program Achieves 84% Colorectal Cancer Screening Rate Through Industry Collaboration

THOMSON REUTERS
·
Mar 03

Privia Health Director Morris Matthew Shawn Disposes of Common Shares

Reuters
·
Mar 03

Privia Health Is Maintained at Buy by Truist Securities

Dow Jones
·
Mar 02

Truist Adjusts Price Target on Privia Health to $33 From $31, Maintains Buy Rating

MT Newswires Live
·
Mar 02

Privia Health Group (PRVA) Gets a Buy from Truist Financial

TIPRANKS
·
Mar 02

Privia Health Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
Feb 28